# Candel Therapeutics, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:05c4115e-720f-4c0d-a311-afbbb92de584 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/candel-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:16.320231+00:00 | | Last reviewed | 2026-10-17T04:46:16.320231+00:00 | ## Identity - Legal name: Candel Therapeutics, Inc. - Display name: Candel Therapeutics, Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T06:22:49.031662+00:00 | | Completeness | 0.409 | | Record Quality | 0.848 | | Directors | 9 | | Committees | 3 | | Governance events | 17 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Christopher Martell: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (chair); Audit · Chair (member). claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:5 - Diem Nguyen, Ph.D., M.B.A.: Director. Status: current. Independent: true. Since: 2021-01-01. claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:6 - Edward J. Benz, Jr., M.D.: Director. Status: current. Independent: true. Since: 2017-01-01. claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:7 - Gary J. Nabel, M.D., Ph.D.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:8 - Joseph C. Papa, R.Ph., M.B.A.: Director. Status: current. Independent: true. Since: 2022-01-01. claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:9 - Nicoletta Loggia, Ph.D., R.Ph.: Director. Status: current. Independent: true. Since: 2023-01-01. claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:10 - Paul B. Manning: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:11 - Paul Peter Tak, M.D., Ph.D., FMedSci: Director. Status: current. Independent: false. Since: 2020-01-01. claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:12 - Renee Gaeta: Director. Status: current. Independent: true. Since: 2022-01-01. Committees: Audit (member). claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:13 ## Committees - Audit (audit). Chair: Christopher Martell. Members: Christopher Martell (chair, current); Renee Gaeta (member, current). committee_id=alpha:committee:candel-therapeutics-inc:audit - Audit · Chair (audit). Chair: NOT_PUBLISHED. Members: Christopher Martell (member, current). committee_id=alpha:committee:candel-therapeutics-inc:audit-chair - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Paul B. Manning (member, current). committee_id=alpha:committee:candel-therapeutics-inc:compensation ## Executive leadership - Charles Schoch: Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:14 - Francesca Barone, M.D., Ph.D.: Chief Scientific Officer. Status: current. claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:15 - Paul Peter Tak, M.D., Ph.D., FMedSci: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:16 - Seshu Tyagarajan, Ph.D., RAC: Chief Technical and Development Officer. Status: current. claim_id=alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:17 ## Governance events - CFO_CHANGED: Charles Schoch executive of Candel Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:1vrr7ojkmo8u9 - EXECUTIVE_APPOINTED: Francesca Barone, M.D., Ph.D. executive of Candel Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:e2wxiupstiqy - CEO_CHANGED: Paul Peter Tak, M.D., Ph.D., FMedSci executive of Candel Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:vlghw21ou6whc - EXECUTIVE_APPOINTED: Seshu Tyagarajan, Ph.D., RAC executive of Candel Therapeutics, Inc., effective 2026-04-29. Effective: 2026-04-29. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:cugx5ea6h9uq - DIRECTOR_APPOINTED: Nicoletta Loggia, Ph.D., R.Ph. seat on Candel Therapeutics, Inc., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:13gui07pyndb - DIRECTOR_APPOINTED: Gary J. Nabel, M.D., Ph.D. seat on Candel Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:1dp11vdv3kjqj - DIRECTOR_APPOINTED: Joseph C. Papa, R.Ph., M.B.A. seat on Candel Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:o7bs7g1hjm8q - DIRECTOR_APPOINTED: Renee Gaeta seat on Candel Therapeutics, Inc., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:oj0ldph0ma1x - COMMITTEE_MEMBER_ADDED: Renee Gaeta member of Audit, effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:f35o22g0tzus - DIRECTOR_APPOINTED: Diem Nguyen, Ph.D., M.B.A. seat on Candel Therapeutics, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:na9s9u1j2aa5e - DIRECTOR_APPOINTED: Paul Peter Tak, M.D., Ph.D., FMedSci seat on Candel Therapeutics, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:1d124e61xtlqom - DIRECTOR_APPOINTED: Christopher Martell seat on Candel Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:xvgxd51d787pz - DIRECTOR_APPOINTED: Paul B. Manning seat on Candel Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:akfap2xpcd5q - COMMITTEE_CREATED: Audit · Chair committee of Candel Therapeutics, Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:oipurv3m5d3v - COMMITTEE_MEMBER_ADDED: Christopher Martell member of Audit · Chair, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:wgfqeyhagplq - COMMITTEE_MEMBER_ADDED: Paul B. Manning member of Compensation, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:14ibbgqhh6zre - DIRECTOR_APPOINTED: Edward J. Benz, Jr., M.D. seat on Candel Therapeutics, Inc., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:16.320231+00:00. event_id=alpha:event:transition:1gg295ujo4sum ## Scoped resources - `alpha://company/candel-therapeutics-inc` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record - `alpha://company/candel-therapeutics-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=identity - `alpha://company/candel-therapeutics-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=corporate-structure - `alpha://company/candel-therapeutics-inc/board` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=board - `alpha://company/candel-therapeutics-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=committees - `alpha://company/candel-therapeutics-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=leadership - `alpha://company/candel-therapeutics-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=ownership - `alpha://company/candel-therapeutics-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=financials - `alpha://company/candel-therapeutics-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=capital-structure - `alpha://company/candel-therapeutics-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=compensation - `alpha://company/candel-therapeutics-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=governance - `alpha://company/candel-therapeutics-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=shareholder-governance - `alpha://company/candel-therapeutics-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=audit - `alpha://company/candel-therapeutics-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=legal - `alpha://company/candel-therapeutics-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=risk - `alpha://company/candel-therapeutics-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=cyber - `alpha://company/candel-therapeutics-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=ai-governance - `alpha://company/candel-therapeutics-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=agents - `alpha://company/candel-therapeutics-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=ecosystem - `alpha://company/candel-therapeutics-inc/events` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=events - `alpha://company/candel-therapeutics-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=relationships - `alpha://company/candel-therapeutics-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=assessments - `alpha://company/candel-therapeutics-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:christopher-martell","name":"Christopher Martell"},"source_id":"board_seats"}` - Claim alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:renee-gaeta","name":"Renee Gaeta"},"source_id":"board_seats"}` - Claim alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:paul-b-manning","name":"Paul B. Manning"},"source_id":"board_seats"}` ## Leadership - Christopher Martell: Director, Audit · Chair. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:5. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:042a378d6105e1085d9473eee3f1d6fb6520aa850498ec10dfcb0fbedd4d4f0e. - Diem Nguyen, Ph.D., M.B.A.: Director. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:6. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:042a378d6105e1085d9473eee3f1d6fb6520aa850498ec10dfcb0fbedd4d4f0e. - Edward J. Benz, Jr., M.D.: Director. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:7. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:042a378d6105e1085d9473eee3f1d6fb6520aa850498ec10dfcb0fbedd4d4f0e. - Gary J. Nabel, M.D., Ph.D.: Director. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:8. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:042a378d6105e1085d9473eee3f1d6fb6520aa850498ec10dfcb0fbedd4d4f0e. - Joseph C. Papa, R.Ph., M.B.A.: Director. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:9. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:042a378d6105e1085d9473eee3f1d6fb6520aa850498ec10dfcb0fbedd4d4f0e. - Nicoletta Loggia, Ph.D., R.Ph.: Director. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:10. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:042a378d6105e1085d9473eee3f1d6fb6520aa850498ec10dfcb0fbedd4d4f0e. - Paul B. Manning: Director, Compensation. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:11. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:042a378d6105e1085d9473eee3f1d6fb6520aa850498ec10dfcb0fbedd4d4f0e. - Paul Peter Tak, M.D., Ph.D., FMedSci: Director. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:12. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:042a378d6105e1085d9473eee3f1d6fb6520aa850498ec10dfcb0fbedd4d4f0e. - Renee Gaeta: Director, Audit. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:13. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:042a378d6105e1085d9473eee3f1d6fb6520aa850498ec10dfcb0fbedd4d4f0e. - Charles Schoch: Chief Financial Officer. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:14. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:80152945f754b89856d2be71896b5a96dc5e48d7e457b0c08278a63259f46c15. - Francesca Barone, M.D., Ph.D.: Chief Scientific Officer. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:15. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b0718fc3cc7e370e79b681d4a789d0e8850702fd1a637a324df896a2c47f0645. - Paul Peter Tak, M.D., Ph.D., FMedSci: Chief Executive Officer. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:16. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f9493ed89f952adfe961c8cda280d2528f58c2fc85bc244e56fcafa9d399232d. - Seshu Tyagarajan, Ph.D., RAC: Chief Technical and Development Officer. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:leadership_role:17. Valid from: 2026-04-29. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5fd90e420be9e7824e53c4745844ac6b2ae94a06056105c986353c7aee7edb41. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Christopher Martell; Members Christopher Martell (Chair); Renee Gaeta. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:committee_record:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6cc5dda440983a8e98dd89353f247aa06dc55a54dc1ab31c2c2c1e3ce2c0e6b8. - Compensation: Chair not stated; Members Paul B. Manning. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6cc5dda440983a8e98dd89353f247aa06dc55a54dc1ab31c2c2c1e3ce2c0e6b8. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Candel Therapeutics, Inc.. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fc580912821af0992b81698b723f4daec4ae6c0b502894456b8855faee24cf89. ## Entity Status - Public listing published. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fc580912821af0992b81698b723f4daec4ae6c0b502894456b8855faee24cf89. ## Published Fact - US. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fc580912821af0992b81698b723f4daec4ae6c0b502894456b8855faee24cf89. ## Committee Appointment - Christopher Martell: chair, Audit. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6cc5dda440983a8e98dd89353f247aa06dc55a54dc1ab31c2c2c1e3ce2c0e6b8. - Renee Gaeta: member, Audit. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6cc5dda440983a8e98dd89353f247aa06dc55a54dc1ab31c2c2c1e3ce2c0e6b8. - Paul B. Manning: member, Compensation. Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:6cc5dda440983a8e98dd89353f247aa06dc55a54dc1ab31c2c2c1e3ce2c0e6b8. ## Security Listing - CADL (NASDAQ). Claim: alpha:claim:company:05c4115e-720f-4c0d-a311-afbbb92de584:security_listing:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:fc580912821af0992b81698b723f4daec4ae6c0b502894456b8855faee24cf89. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:fc580912821af0992b81698b723f4daec4ae6c0b502894456b8855faee24cf89: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/candel-therapeutics-inc). - alpha:projection-evidence:document:042a378d6105e1085d9473eee3f1d6fb6520aa850498ec10dfcb0fbedd4d4f0e: [Candel Therapeutics, Inc. DEF 14A 2025-04-29](https://www.sec.gov/Archives/edgar/data/1841387/000095017025060093/cadl-20250429.htm). - alpha:projection-evidence:document:80152945f754b89856d2be71896b5a96dc5e48d7e457b0c08278a63259f46c15: [CADL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1841387/000119312526191506/cadl-20260429.htm). - alpha:projection-evidence:document:b0718fc3cc7e370e79b681d4a789d0e8850702fd1a637a324df896a2c47f0645: [CADL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1841387/000119312526191506/cadl-20260429.htm). - alpha:projection-evidence:document:f9493ed89f952adfe961c8cda280d2528f58c2fc85bc244e56fcafa9d399232d: [CADL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1841387/000119312526191506/cadl-20260429.htm). - alpha:projection-evidence:document:5fd90e420be9e7824e53c4745844ac6b2ae94a06056105c986353c7aee7edb41: [CADL DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1841387/000119312526191506/cadl-20260429.htm). - alpha:projection-evidence:6cc5dda440983a8e98dd89353f247aa06dc55a54dc1ab31c2c2c1e3ce2c0e6b8: [Audit](https://www.sec.gov/Archives/edgar/data/1841387/000095017025060093/cadl-20250429.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/candel-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/candel-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/candel-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/candel-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T06:22:48.801236+00:00; recorded 2026-10-17T06:22:48.801236+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.